Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant allergens for immunotherapy. Where do we stand?

Verena Niederberger1, Rudolf Valenta

  • 1Department of Otorhinolaryngology, Centre for Physiology and Pathophysiology, Vienna General Hospital, Medical University of Vienna, A-1090 Vienna, Austria.

Current Opinion in Allergy and Clinical Immunology
|January 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Involution of IgE sensitization to house dust mite allergen molecules by age.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Irritant occupational exposure and specific-IgE sensitisation in the EGEA cohort.

Occupational and environmental medicine·2026
Same author

Discovery of tumor antigens in renal cell carcinoma and prospects for clinical application.

Frontiers in immunology·2026
Same author

Birch Pollen Exposure Boosts Mal d 1-Specific IgE and Sensitivity to Apple.

Allergy·2026
Same author

Reply.

The Journal of allergy and clinical immunology·2026
Same author

Algorithms in Allergy: General Allergen Molecule-Based Algorithm for Allergen-Specific Immunotherapy.

Allergy·2026

Recombinant allergens offer a promising alternative to traditional treatments for allergies. These advancements in recombinant allergen-specific immunotherapy and diagnostics are paving the way for more effective allergy vaccines.

Area of Science:

  • Allergen immunotherapy
  • Biotechnology
  • Clinical immunology

Background:

  • Current therapeutic allergen extracts have significant limitations.
  • Recombinant allergens are emerging as potential replacements.
  • Advancements bridge laboratory research and clinical use.

Purpose of the Study:

  • To review the development of recombinant allergens for clinical applications.
  • To highlight the potential of recombinant allergens in improving allergen-specific immunotherapy.
  • To discuss new diagnostic and vaccine technologies.

Main Methods:

  • Review of recent studies on recombinant allergen technology.
  • Analysis of clinical trials involving recombinant allergens.
  • Exploration of peptide and genetic engineering for vaccine development.

Related Experiment Videos

Main Results:

  • Recombinant allergens show potential to replace current extracts.
  • Recombinant allergen-based diagnostics aid patient selection for immunotherapy.
  • New allergy vaccines targeting B cells, T cells, or both are being developed.
  • Early immunotherapy trials with genetically engineered allergens show encouraging results.

Conclusions:

  • Recombinant allergen diagnostics will enhance patient selection for immunotherapy.
  • The first immunotherapy trial with recombinant allergens offers insights into mechanisms.
  • New allergy vaccines based on recombinant allergens are anticipated soon.